Immunoglobulin-free light chain monomer-dimer patterns help to distinguish malignant from premalignant monoclonal gammopathies: A pilot study

American Journal of Hematology

Volumn 89, Issue 9, 2014, Pages 882-888

  Kaplan, Batia ^a   Golderman, Sizilia ^a   Aizenbud, Boris ^b   Esev, Konstantin ^c   Kukuy, Olga ^c   Leiba, Merav ^c   Livneh, Avi ^a,c,d   Ben Zvi, Ilan ^c,d  

^a HELLER INSTITUTE OF MEDICAL RESEARCH   (Israel)

^b Elta Electronics Industries Ltd   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; IMMUNOGLOBULIN LIGHT CHAIN; MONOMER;

AL AMYLOIDOSIS; AMYLOIDOSIS; ARTICLE; CANCER PATIENT; CLONAL VARIATION; CONTROLLED STUDY; DIMERIZATION; FREE LIGHT CHAIN; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIGHT CHAIN; MAJOR CLINICAL STUDY; MONOCLONAL GAMMOPATHY OF UNKNOWN SIGNIFICANCE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PRIORITY JOURNAL; QUANTITATIVE STUDY; SMOLDERING MYELOMA; WESTERN BLOTTING;

AMYLOIDOSIS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE; MULTIPLE MYELOMA; PILOT PROJECTS; PROTEIN MULTIMERIZATION; SENSITIVITY AND SPECIFICITY;

EID: 84906095087     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23773     Document Type: Article

References (20)

1. Gallo GR, Feiner HD, Chuba JV, et al. Characterization of tissue amyloid by immunofluorescence microscopy. Clin Immunol Immunopathol 1986;39(3):479-490.
2. Kaplan B, Martin BM, Livneh A, et al. Biochemical micro-techniques in the diagnosis and classification of amyloidosis. Curr Pharm Anal 2006;2:45-52.
3. Murphy CL, Wang S, Williams T, et al. Characterization of systemic amyloid deposits by mass spectrometry. Method Enzymol 2006;412:48-62.
4. Brambilla F, Lavatelli F, Merlini G, Mauri P. Clinical proteomics for diagnosis and typing of systemic amyloidoses. Proteomics Clin Appl 2013;7(1-2):136-143.
5. Katzmann JA, Clark RJ, Abraham RS, et al. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: Relative sensitivity for detection of monoclonal light chains. Clin Chem 2002;48(9):1437-1444.
6. Bradwell AR. Serum Free Light Chain Assays, 6th ed. Birmingham, UK: The Binding Site Ltd; 2010. pp 130-147.
7. Tate J, Bazeley S, Sykes S, Mollee P. Quantitative serum free light chain assay: Analytical issues. Clin Biochem Rev 2009;30(3):131-140.
8. Li C, Geng H, Yang Z, Zhong R. Influence of immunoglobulin light chain dimers on the results of the quantitative nephelometric assay. Clin Lab 2011;5(1-2):53-57.
9. Lachmann HJ, Gallimore R, Gillmore JD, et al. Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy. Br J Haematol 2003;122(1):78-84.
10. Kaplan B, Ramirez-Alvarado M, Sikkink L, et al. Free light chains in plasma of patients with light chain amyloidosis and non-amyloid light chain deposition disease. High proportion and heterogeneity of disulfide-linked monoclonal free light chains as pathogenic features of amyloid disease. Br J Haematol 2009;144(5):705-715.
11. Kaplan B, Golderman S, Yahalom G, et al. Free light chain monomer-dimer patterns in the diagnosis of multiple sclerosis. J Immunol Meth 2013;390(1-2):74-80.
12. Kaplan B, Aizenbud BM, Golderman S, et al. Free light chain monomers in the diagnosis of multiple sclerosis. J Neuroimmunol 2010;229(1-2):263-271.
13. Bergström J, Murphy C, Eulitz M, et al. Codeposition of apolipoprotein A-IV and transthyretin in senile systemic (ATTR) amyloidosis. Biochem Biophys Res Commun 2001;285(4):903-908.
14. Galuske RA, Drach LM, Nichtweiss M, et al. Colocalization of different types of amyloid in the walls of cerebral blood vessels of patients suffering from cerebral amyloid angiopathy and spontaneous intracranial hemorrhage: a report of 5 cases. Clin Neuropathol 2004;23(3):113-119.
15. Picken, MM, Herrera, GA. The burden of "Sticky" amyloid: Typing challenges. Arch Pathol Lab Med 2007;131(6):850-851.
16. Kaplan B, Livneh A, Sela B. Immunoglobulin free light chain dimers in human diseases. Sci World J 2011;11:726-735.
17. Wilkinson B, Gilbert H. Protein disulfide isomerase. Biochem Biophys Acta 2004;16999(1-2):35-44.
18. Xiao R, Lundstrom-Ljung J, Holmgren A, Gilbert HF. Catalysis of thiol/disulfide exchange J Biol Chem 2005;280(22):21099-21106.
19. Migrino RQ, Hari P, Gutterman DD, et al. Systemic and microvascular oxidative stress induced by light chain amyloidosis. Int J Cardiol 2010;145(1):67-68.
20. Sharma A, Tripathi M, Satyam A, Kumar L. Study on antioxidant level in patients with multiple myeloma. Leuk Lymphoma 2009;50(5):809-815.